Ken Griffin Nexgel, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nexgel, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 15,381 shares of NXGL stock, worth $33,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,381Holding current value
$33,222% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NXGL
# of Institutions
14Shares Held
155KCall Options Held
0Put Options Held
0-
Simon Quick Advisors, LLC35.7KShares$77,1440.01% of portfolio
-
Geode Capital Management, LLC Boston, MA30.3KShares$65,3910.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.6KShares$55,3620.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.5KShares$55,1360.0% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA11.8KShares$25,5910.01% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $12M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...